Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem Prolonged Infusion in Pediatric CF Exacerbation
NCT01429259Phase 4Completed
- Start
- Feb 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of meropenem in Pseudomonas aeruginosa infection, pneumonia. Started Feb 2012; status: completed.
02
Drugs
meropenem
03
Conditions
Pseudomonas aeruginosa infectionpneumonia
Beyond the preview
Go deeper on NCT01429259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01429259.